We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+3.46%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
-$19.3M
(-12%)
Cap. Flow
-$14.1M
Cap. Flow
% of AUM
-9.94%
Top 10 Holdings %
Top 10 Hldgs %
45.5%
Holding
348
New
34
Increased
31
Reduced
40
Closed
93
Avg Time Held Equity + Options
3.2
quarters
Top 10 Avg Time Held Equity + Options
1.6
quarters
Top 20 Avg Time Held Equity + Options
2.4
quarters
Avg Time Held Equity only
3.3
quarters
Top 10 Avg Time Held Equity only
2.5
quarters
Top 20 Avg Time Held Equity only
2.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Par Pacific Holdings
PARR
|
+$1.12M |
| 2 |
RAX
Rackspace Hosting Inc
RAX
|
+$830K |
| 3 |
Trina Solar Limited
TSL
|
+$687K |
| 4 |
Children's Place
PLCE
|
+$506K |
| 5 |
Qualys
QLYS
|
+$504K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$1.72M |
| 2 |
Wolfspeed
WOLF
|
+$999K |
| 3 |
Revance Therapeutics, Inc.
RVNC
|
+$850K |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$813K |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$623K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.34% |
| 2 | Miscellaneous | 32.26% |
| 3 | Healthcare | 9.02% |
| 4 | Technology | 5.11% |
| 5 | Consumer Discretionary | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CTIC
151
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $97K | 0.07% |
4,000
-1,000
| -20% | -$26K |
2013 Q2
5 quarters
|
|
|
BKMU
152
DELISTED
Bank Mutual Corp
BKMU
| $96K | 0.07% |
+15,000
| New | +$93.8K |
2014 Q3
0 quarters
|
|
|
FWM
153
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
| $94K | 0.07% |
+25,000
| New | +$127K |
2014 Q3
0 quarters
|
|
154
DELISTED
GENERAL MTRS CO WTS EXP 12/31/15 (DE)
GM.WS.C
| $91K | 0.06% |
105,000
| – | – |
2013 Q3
4 quarters
|
|
155
The Bancorp
TBBK
$2B
| $86K | 0.06% |
+10,000
| New | +$98.6K |
2014 Q3
0 quarters
|
|
156
Heron Therapeutics
HRTX
$78.9M
| $83K | 0.06% |
10,000
-6,362
| -39% | -$59.2K |
2013 Q2
5 quarters
|
|
157
NovaGold Resources
NG
$2.95B
| $76K | 0.05% |
25,000
-25,000
| -50% | -$93.8K |
2014 Q1
2 quarters
|
|
158
Curis
CRIS
$1.56M
| $71K | 0.05% |
25
| – | – |
2013 Q2
5 quarters
|
|
|
GCVRZ
159
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $70K | 0.05% |
150,000
+50,000
| +50% | +$24.3K |
2013 Q2
5 quarters
|
|
|
ANR
160
DELISTED
Alpha Natural Resources Inc
ANR
| $62K | 0.04% |
25,000
| – | – |
2013 Q4
3 quarters
|
|
161
Fortress Biotech
FBIO
$70.4M
| $53K | 0.04% |
1,667
-1,666
| -50% | -$44.2K |
2013 Q2
5 quarters
|
|
|
FCSC
162
DELISTED
Fibrocell Science Inc.
FCSC
| $44K | 0.03% |
1,000
| – | – |
2013 Q4
3 quarters
|
|
163
DELISTED
Associated Banc-Corp Warrants
ASB.WS
| $43K | 0.03% |
20,000
| – | – |
2013 Q2
5 quarters
|
|
|
TCF.WS
164
DELISTED
TCF Financial Corporation
TCF.WS
| $42K | 0.03% |
15,800
| – | – |
2013 Q2
5 quarters
|
|
|
PLM
165
DELISTED
PolyMet Mining Corp.
PLM
| $41K | 0.03% |
3,750
| – | – |
2013 Q2
5 quarters
|
|
166
Aware
AWRE
$21.8M
| $37K | 0.03% |
10,000
| – | – |
2013 Q4
3 quarters
|
|
167
DELISTED
CASI Pharmaceuticals
CASI
| $36K | 0.03% |
2,000
| – | – |
2013 Q2
5 quarters
|
|
|
LIQD
168
DELISTED
LIQUID HLDGS GROUP INC COM STK (DE)
LIQD
| $34K | 0.02% |
25,000
| – | – |
2014 Q2
1 quarter
|
|
169
Alaunos Therapeutics
TCRT
$2.67M
| $26K | 0.02% |
67
| – | – |
2013 Q3
4 quarters
|
|
170
Ur-Energy
URG
$367M
| $26K | 0.02% |
25,000
| – | – |
2014 Q1
2 quarters
|
|
171
DELISTED
Citigroup Inc
C.WS.A
| $24K | 0.02% |
25,000
| – | – |
2013 Q2
5 quarters
|
|
172
DELISTED
Cel-Sci Corp Series S
CVM.WS
| $22K | 0.02% |
100,000
+10,000
| +11% | +$2.55K |
2014 Q2
1 quarter
|
|
|
ECTE
173
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
| $21K | 0.01% |
25,000
| – | – |
2013 Q2
5 quarters
|
|
|
ADXSW
174
DELISTED
Advaxis Inc Warrants
ADXSW
| $17K | 0.01% |
12,500
| – | – |
2013 Q4
3 quarters
|
|
175
Oragenics
OGEN
$2.02M
| $13K | 0.01% |
1
| – | – |
2013 Q4
3 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q3 2014 Portfolio in Review
As of Q3 2014, E.E. Geduld held 348 positions worth $142M, down 12% from $161M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
E.E. Geduld withdrew a net $14.1M in Q3 2014, closing 93 positions and reducing 40 holdings. Its most notable exit was Verizon, an estimated $1.72M position sold in full.
By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Par Pacific Holdings worth $1.07M.
- E.E. Geduld's largest Q3 2014 buy was Par Pacific Holdings: 63,482 shares worth $1.07M.
- E.E. Geduld added most to Qualys in Q3 2014, an estimated $504K increase.
- E.E. Geduld's biggest Q3 2014 reduction was Mellanox Technologies, Ltd., cutting an estimated $813K.
- E.E. Geduld fully exited Verizon in Q3 2014, selling an estimated $1.72M.
- E.E. Geduld's ten largest holdings make up 46% of its $142M portfolio in Q3 2014.
- E.E. Geduld opened 34 new positions and closed 93 in Q3 2014.
- E.E. Geduld's portfolio value fell 12% quarter-over-quarter to $142M.
Based on E.E. Geduld's 13F filing for Q3 2014, filed 30 Oct 2014.